Results 4,241-4,260 of 14,090 for speaker:Marc MacSharry
- Written Answers — Department of Health: Disease Management (20 Nov 2018)
Marc MacSharry: 334. To ask the Minister for Health if his attention has been drawn to the fact that denial of treatment options that meet internationally accepted standards for chronic Lyme disease patients is a human rights violation (details supplied); and if he will make a statement on the matter. [47701/18]
- Written Answers — Department of Health: Qualifications Recognition (13 Nov 2018)
Marc MacSharry: 307. To ask the Minister for Health the timeframe for bringing forward amendments to section 38(2)(b) of the Health and Social Care Professionals Act 2005, as amended, to accept qualification recognition decisions made here under directives which preceded Directive 2005/36/EC, that is, Directives 89/48 and-or 92/51; and if he will make a statement on the matter. [46482/18]
- Written Answers — Department of Health: Medicinal Products Availability (13 Nov 2018)
Marc MacSharry: 330. To ask the Minister for Health if the case of a person (details supplied) in County Sligo will be reviewed; and if he will make a statement on the matter. [46604/18]
- Written Answers — Department of Employment Affairs and Social Protection: Social Welfare Benefits Eligibility (13 Nov 2018)
Marc MacSharry: 551. To ask the Minister for Employment Affairs and Social Protection the changes being applied to a practice (details supplied); her plans to make changes to this practice in the forthcoming social welfare Bill; and if she will make a statement on the matter. [46571/18]
- Public Accounts Committee: Business of Committee (8 Nov 2018)
Marc MacSharry: As it has a lot more correspondence than we do, it will know a lot more about it.
- Public Accounts Committee: Business of Committee (8 Nov 2018)
Marc MacSharry: As it will know a lot more than us, I would not worry about it.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I welcome the witnesses. Who in the State Claims Agency directs a case? If I am taking a case, I brief my solicitor on the outcome I would like to achieve. Who in the State Claims Agency does this?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: When a case ends up with the State Claims Agency, is the agency briefed by the Department or the Minister or is its only modus operandito protect the State and minimise exposure?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Or a Minister, if the action is being taken against him or her or any of the State agencies within his or her remit.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Does the State Claims Agency have plenipotentiary status to direct a case without any toing and froing with the Department or the Minister or does that interaction take place?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I understand that. Mr. Breen says the State Claims Agency investigates it. It investigates matters with its preferred outcome, which is presumably to minimise exposure to the State.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Mr. Breen might have referred to this with Deputy Connolly earlier. In cases overall, how often does the agency pay people off or settle without any litigation and say there might be an issue and that the agency is prepared to pay a certain amount?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Normally the agency would not, so it would end up in court.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: What percentage ends up in court?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Is being under case management different from being in court? I do not know the legalese.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: When Mr. Breen says "in court", he is not including that process.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: In the room?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: With regard to litigation, Mr. Breen would not associate discovery as being in court.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I am maybe not as up to date on the thalidomide issue as some other members. An offer of €62,500 was made. Had Mr. Breen a different role in the State Claims Agency at that point?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: So he was negotiating and made this offer.